Open AccessOR27-3 Long-Term Results from the Phase III LINC 4 Study: Osilodrostat Maintained Normal Mean Urinary Free Cortisol in Patients with Cushing's Disease, with a Favorable Safety Profile
Author(s) -
Richard J. Auchus,
Zhanna Belaya,
Marie Bex,
Richard A Feelders,
Anthony P. Heaney,
Manabi Paul,
Alberto M Pedroncelli,
Peter J. Snyder,
Adina F. Turcu,
Przemysław Witek,
Mônica R. Gadelha
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1094
Subject(s) - tolerability , medicine , adverse effect , placebo , urinary system , gastroenterology , pathology , alternative medicine